Search research articles
Contact Us
Filters
Showing results (1-10 of 6) with videos related to
Page
of 1
Sort By:
Biometrics
|
April 11, 2016
Single-index varying coefficient model for functional responses
Xinchao Luo, Lixing Zhu, Hongtu Zhu
Information Processing in Medical Imaging : Proceedings of the ... Conference
|
July 28, 2015
Functional Nonlinear Mixed Effects Models for Longitudinal Image Data
Xinchao Luo, Lixing Zhu, Linglong Kong, et al.
Statistica Sinica
|
November 21, 2019
FMEM: Functional Mixed Effects Models for Longitudinal Functional Responses
Hongtu Zhu, Kehui Chen, Xinchao Luo, et al.
Drug Design, Development and Therapy
|
March 6, 2025
Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of Milvexian in Healthy Chinese Adults
Zhu Luo, Jie Wang, Zhuolu Niu, et al.
Haematologica
|
October 9, 2025
Talquetamab, a GPRC5D×CD3 bispecific antibody, in Chinese patients with relapsed/refractory multiple myeloma: efficacy and safety from the phase 1/2 MonumenTAL-1 study
Gang An, Jie Jin, Zhen Cai, et al.
Cancer
|
December 11, 2024
Efficacy, safety, and pharmacokinetics of teclistamab in Chinese patients with relapsed/refractory multiple myeloma from the China cohort of MajesTEC-1
Zhen Cai, Zhongjun Xia, Ai-Li He, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 6) with videos related to
Sort By:
Page
of 1
Biometrics
|
April 11, 2016
Single-index varying coefficient model for functional responses
Xinchao Luo, Lixing Zhu, Hongtu Zhu
Information Processing in Medical Imaging : Proceedings of the ... Conference
|
July 28, 2015
Functional Nonlinear Mixed Effects Models for Longitudinal Image Data
Xinchao Luo, Lixing Zhu, Linglong Kong, et al.
Statistica Sinica
|
November 21, 2019
FMEM: Functional Mixed Effects Models for Longitudinal Functional Responses
Hongtu Zhu, Kehui Chen, Xinchao Luo, et al.
Drug Design, Development and Therapy
|
March 6, 2025
Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of Milvexian in Healthy Chinese Adults
Zhu Luo, Jie Wang, Zhuolu Niu, et al.
Haematologica
|
October 9, 2025
Talquetamab, a GPRC5D×CD3 bispecific antibody, in Chinese patients with relapsed/refractory multiple myeloma: efficacy and safety from the phase 1/2 MonumenTAL-1 study
Gang An, Jie Jin, Zhen Cai, et al.
Cancer
|
December 11, 2024
Efficacy, safety, and pharmacokinetics of teclistamab in Chinese patients with relapsed/refractory multiple myeloma from the China cohort of MajesTEC-1
Zhen Cai, Zhongjun Xia, Ai-Li He, et al.
Page
of 1